Korey Johnson

The time for a better UX in digital therapeutics is now

If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.

read more

How to prepare products for global research

Twenty years of global research have taught us (sometimes the hard way) that challenges can arise when prepping devices or other products for international research. When not accounted for, these factors can threaten the validity of insights gleaned from the research, or at minimum introduce...

read more

Human factors research in the times of COVID

How to continue to support development of safe and effective medical devices Many thought pieces are being pushed out around what remote research methods are available to replace research that would have otherwise been conducted in person if not for COVID. We’ve published some ourselves (Three...

read more

The time for a better UX in digital therapeutics is now

If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.

read more